Evolva Holding SA (EVE.SW)

CHF 0.84

(-6.44%)

Long Term Debt Summary of Evolva Holding SA

Evolva Holding SA's latest annual long term debt in 2023 was - CHF , down -100.0% from previous year.
Evolva Holding SA's latest quarterly long term debt in 2024 Q2 was - CHF , down 0.0% from previous quarter.
Evolva Holding SA reported annual long term debt of 2.9 Million CHF in 2022, down -18.67% from previous year.
Evolva Holding SA reported annual long term debt of 3.57 Million CHF in 2021, down -14.47% from previous year.
Evolva Holding SA reported quarterly long term debt of - CHF for 2023 FY, down -100.0% from previous quarter.
Evolva Holding SA reported quarterly long term debt of - CHF for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Evolva Holding SA (2023 - 2005)

Historical Annual Long Term Debt of Evolva Holding SA (2023 - 2005)

Year	Long Term Debt	Long Term Debt Growth
2023	- CHF	-100.0%
2022	2.9 Million CHF	-18.67%
2021	3.57 Million CHF	-14.47%
2020	4.17 Million CHF	-13.67%
2019	4.84 Million CHF	102.18%
2018	2.39 Million CHF	-0.25%
2017	2.4 Million CHF	-32.66%
2016	3.56 Million CHF	-13.78%
2015	4.13 Million CHF	5.88%
2014	3.9 Million CHF	13.04%
2013	3.45 Million CHF	-3.92%
2012	3.59 Million CHF	-4.52%
2011	3.76 Million CHF	-2.18%
2010	3.84 Million CHF	-57.34%
2009	9.02 Million CHF	0.0%
2008	- CHF	-100.0%
2007	5.13 Million CHF	-1.34%
2006	5.2 Million CHF	0.0%
2005	- CHF	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- CHF	0.0%
2023 FY	- CHF	-100.0%
2023 Q4	- CHF	0.0%
2023 Q2	3.05 Million CHF	0.0%
2022 Q4	2.9 Million CHF	0.0%
2022 Q2	3.17 Million CHF	0.0%
2022 FY	2.9 Million CHF	-18.67%
2021 Q4	3.57 Million CHF	0.0%
2021 Q2	3.8 Million CHF	0.0%
2021 FY	3.57 Million CHF	-14.47%
2020 FY	4.17 Million CHF	-13.67%
2020 Q2	4.49 Million CHF	0.0%
2020 Q4	4.17 Million CHF	0.0%
2019 Q2	5.33 Million CHF	0.0%
2019 FY	4.84 Million CHF	102.18%
2019 Q4	4.84 Million CHF	0.0%
2018 Q2	2.68 Million CHF	0.0%
2018 Q4	2.39 Million CHF	0.0%
2018 FY	2.39 Million CHF	-0.25%
2017 FY	2.4 Million CHF	-32.66%
2017 Q4	2.4 Million CHF	0.0%
2017 Q2	3.26 Million CHF	0.0%
2016 Q4	3.56 Million CHF	0.0%
2016 Q2	3.88 Million CHF	0.0%
2016 FY	3.56 Million CHF	-13.78%
2015 Q4	4.13 Million CHF	0.0%
2015 FY	4.13 Million CHF	5.88%
2015 Q2	4.63 Million CHF	0.0%
2014 FY	3.9 Million CHF	13.04%
2014 Q2	3.26 Million CHF	0.0%
2014 Q4	3.9 Million CHF	0.0%
2013 Q4	3.45 Million CHF	0.0%
2013 Q2	3.47 Million CHF	0.0%
2013 FY	3.45 Million CHF	-3.92%
2012 Q2	5.77 Million CHF	0.0%
2012 Q4	3.59 Million CHF	0.0%
2012 FY	3.59 Million CHF	-4.52%
2011 Q4	3.76 Million CHF	0.0%
2011 FY	3.76 Million CHF	-2.18%
2011 Q2	6.5 Million CHF	0.0%
2010 Q2	8.69 Million CHF	0.0%
2010 FY	3.84 Million CHF	-57.34%
2010 Q4	3.84 Million CHF	0.0%
2009 Q4	9.02 Million CHF	0.0%
2009 FY	9.02 Million CHF	0.0%
2008 FY	- CHF	-100.0%
2007 FY	5.13 Million CHF	-1.34%
2006 FY	5.2 Million CHF	0.0%
2005 FY	- CHF	0.0%

Peer Long Term Debt Comparison of Evolva Holding SA

Name	Long Term Debt	Long Term Debt Difference
Addex Therapeutics Ltd	70.38 Thousand CHF	100.0%
BB Biotech AG	304.9 Million CHF	100.0%
Basilea Pharmaceutica AG	95.45 Million CHF	100.0%
Idorsia Ltd	931 Million CHF	100.0%
Kuros Biosciences AG	1.56 Million CHF	100.0%
Molecular Partners AG	2.44 Million CHF	100.0%
Relief Therapeutics Holding AG	9000.00 CHF	100.0%
Santhera Pharmaceuticals Holding AG	1.47 Million CHF	100.0%